Skip to main content

Advertisement

Log in

Sacral neuromodulation in patients with multiple sclerosis

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

We present a case series of patients with multiple sclerosis (MS) and neurogenic lower urinary tract dysfunction treated by sacral neuromodulation (SNM).

Methods

We reviewed charts of 25 patients who were treated for refractory lower urinary tract symptoms; during the SNM testing phase, patient management included evaluation of number of daily voiding, number of episodes of incontinence, residual urine and quality of life score. Patients who experienced greater than 50% improvement in symptoms of frequency and incontinence episodes and/or a greater than 50% decrease in the number of catheterizations and a greater than 50% increase in voided volumes were offered placement of the permanent InterStimTM .

Results

Fifteen patients were implanted with InterStimTM; mean duration of MS was 13.66 years; mean follow-up of patients was 49.4 months. Nine patients were on clean intermittent catheterization, and in all of them, a significant decrease in residual volume with increase in voided volume and number of voiding per day; in 6 patients, the main problem was incontinence, and in them incontinence, episodes decreased and voided volume increased. Sixty-six per cent of patients have a functioning device after a mean follow-up of 61.2 months.

Conclusions

SNM is a good option in the treatment of voiding dysfunction in patients with MS in a medium to long-term follow-up. Urinary retention due to detrusor underactivity is not a good indication for SNM; it should be offered to MS patients with refractory urgency urinary incontinence and MS patients with urinary retention due to detrusor-sphincter dyssynergia (DSD).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marinkovic SP, Gillen LM (2010) Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J Pelvic Floor Dysfunct 21(2):223–228

    Article  Google Scholar 

  2. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517

    Article  PubMed  CAS  Google Scholar 

  3. Fowler CJ, van Kerrebroeck PE, Nordenbo A, van Poppel H (1992) Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 55:986–989

    Article  PubMed  CAS  Google Scholar 

  4. Ruud Bosh JLH (1998) Neuromodulation: urodynamic effects of sacral (S3)spinal nerve stimulation in patients with detrusor instability or detrusor hyperreflexia. Behav Brain Res 92:141–150

    Article  Google Scholar 

  5. Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB (2001) Urodynamic pattern changes in multiple sclerosis. Urology 57:239–245

    Article  PubMed  CAS  Google Scholar 

  6. Minardi D, Muzzonigro G (2005) Lower urinary tract and bowel disorders and multiple sclerosis: role of sacral neuromodulation. A preliminary report. Neuromodulation 8:176–181

    Article  PubMed  Google Scholar 

  7. Calabresi PA (2004) Diagnosis and management of multiple sclerosis. Am Fam Physician 70:1935–1944

    PubMed  Google Scholar 

  8. Littwiller SE, Frohman E, Zimmern P (1999) Multiple sclerosis and the urologist. J Urol 161:743–757

    Article  Google Scholar 

  9. Hennessey A, Robertson NP, Swingler R, Compston DA (1999) Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol 246:1027–1032

    Article  PubMed  CAS  Google Scholar 

  10. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D (2007) Disparities in the management of multiple sclerosis –related bladder symptoms. Neurology 68:1971–1978

    Article  PubMed  CAS  Google Scholar 

  11. Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Vespasiani G, Castellano V (1998) Urological dysfunction and upper tract involvement in multiple sclerosis patients. Neurourol Urodyn 17:89–98

    Article  PubMed  CAS  Google Scholar 

  12. DasGupta R, Fowler CJ (1995) Bladder, bowel and sexual dysfunction in multiple sclerosis. Management strategies. Drugs 63:153–166

    Article  Google Scholar 

  13. Burks FN, Diokno AC, Laijness MJ, Ibrahim IA, Peters KM (2008) Sacral neuromodulation reprogramming: is it an office burden. Int Urogynecol J Pelvic Floor Dysfunct 19:1137–1140

    Article  PubMed  Google Scholar 

  14. Roth TM (2007) Sacral neuromodulation and lower urinary tract dysfunction in cerebral plasy. Int Urogynecol J Pelvic Floor Dysfunct 18:567–569

    Article  PubMed  Google Scholar 

  15. De Ridder D, Ost D, van der Aa F, Stagnaro M, Beneton C, Gross-Paju K, Eelen P, Limbourg H, Harper M, Segal JC, Fowler CJ, Nordenbo A (2005) Conservative bladder management in advanced multiple sclerosis. Multiple Scler 11:694–699

    Article  Google Scholar 

  16. Wagner TH, Patrick DL, Bevendam TG, Bueshing DP (1996) Quality of life of persons with urinary incontinence: development of a new measure. Urology 47:67–70

    Article  PubMed  CAS  Google Scholar 

  17. Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P, International Continence Society (2002) Good urodynamic practices: uroflowmetry, filling cystometry and pressure-flow studies. Neurourol Urodyn 21:261–274

    Article  PubMed  Google Scholar 

  18. Minardi D, Parri G, d’Anzeo G, Fabiani A, El Asmar Z, Muzzonigro G (2008) Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infections. J Urol 179:947–951

    Article  PubMed  Google Scholar 

  19. Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F, Giardiello G, De Seta F (on behalf of the GINS group) (2001) Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol 166:541–545

    Google Scholar 

  20. Spinelli M, Sievert KD (2008) Latest technology and surgical developments in using InterStimTM therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol 54:1287–1296

    Article  PubMed  Google Scholar 

  21. Wallace PA, Lane FL, Noblett KL (2007) Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Ostr Gynecol 197(1):96.e1–96.e5

    Article  Google Scholar 

  22. Chartier-Kastler EJ, Ruud Bosch JLH, Perrigot M, Chancellor MB, Richard F, Denys P (2000) Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 164:1476–1480

    Article  PubMed  CAS  Google Scholar 

  23. Bemelmans BL, Mundy AR, Craggs MD (1999) Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol 36:81–91

    Article  PubMed  CAS  Google Scholar 

  24. Bosch JLHR, Groen J (2000) Sacral neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of prospective longitudinal study. J Urol 163:1849–1854

    Article  Google Scholar 

Download references

Acknowledgments

We thank Dr. Limido Lucia (Medtronic—Italia S.p.A.) for technical advice.

Conflict of interest

The authors certify that there is no actual or potential conflict of interest in relation to this article

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniele Minardi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minardi, D., Muzzonigro, G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol 30, 123–128 (2012). https://doi.org/10.1007/s00345-011-0669-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-011-0669-0

Keywords

Navigation